(Q80333811)
Statements
The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension (English)
Martin Busch
Sybille Franke
Gunter Wolf
Antje Brandstädt
Undine Ott
Jens Gerth
Lawrence G Hunsicker
Guenter Stein
Collaborative Study Group